CIAM
TNXP icon

Caitong International Asset Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Caitong International Asset Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,662
Closed -$405K – 2485
2025
Q1 		$405K Buy
+22,662
New +$459K 0.3% 53

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SPS
Susquehanna Portfolio Strategies Bala Cynwyd, Pennsylvania $6.73B AUM 45.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caitong International Asset Management's TNXP Position: Q2 2025 in Review

Caitong International Asset Management sold out of Tonix Pharmaceuticals (TNXP) in Q2 2025, closing a stake of 22,662 shares — an estimated $405K sold.

Caitong International Asset Management first reported a position in TNXP in Q1 2025 and held it in 1 quarter. The position peaked at $405K in Q1 2025. 47 funds tracked by Wall St. Rank hold TNXP as of Q2 2025.

  • Caitong International Asset Management reported no remaining Tonix Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 22,662 Tonix Pharmaceuticals shares in Q2 2025, an estimated $405K.
  • Caitong International Asset Management first reported a position in Tonix Pharmaceuticals in Q1 2025 and held it in 1 quarter.
  • Caitong International Asset Management's Tonix Pharmaceuticals position peaked at $405K in Q1 2025.
  • 47 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2025.

Based on Caitong International Asset Management's 13F filing for Q2 2025, filed 31 Jul 2025.